📄 Recross-examination of Gregory Matheson — Friday, May 5, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\5\RECROSS-EXAMINATION-OF-GREGORY.DOC
TRIAL
▲ Day 68 of 167

Recross-examination of Gregory Matheson

Witness: Gregory Matheson
Examiner: Robert Blasier
Called by: Prosecution • Date: Friday, May 5, 1995 • Utterances: 658
Defense attorney Blasier recrossed LAPD serologist Gregory Matheson, drilling into three main areas: the 1.5 milliliters of unaccounted blood in OJ Simpson's reference vial as of June 20th, significant gaps in the crime lab's physical security records that would allow unauthorized access to go undetected, and the scientific literature on EAP enzyme degradation patterns. Blasier scored a notable point by getting Matheson to concede that the Yeshion article — which Goldberg had raised on redirect — actually supports the defense's theory of BA degradation, not the prosecution's.
1 MR. BLASIER:

Thank you, your Honor.

RECROSS-EXAMINATION BY MR. BLASIER

2 MR. BLASIER:

Now, Mr. Matheson, would you agree that tests that are performed to determine whether something is present or not can only determine that if there's a certain amount of something present? In other words, if there's something less than the sensitivity of the test, you won't detect it, correct?

3 MR. GOLDBERG:

Vague, improper hypothetical.

4 THE COURT:

Overruled.

5 MR. MATHESON:

Yes. If it's below the detectability limit of that test, you won't see it.

6 MR. BLASIER:

So something--it could be present, but your test won't show it?

7 MR. MATHESON:

If it's below that level, yes.

8 MR. BLASIER:

I would like to have--

9 MR. GOLDBERG:

Well, your Honor, I'm sorry. I'm sorry, Mr. Blasier. Is it possible for us to document in some way the way that the vial appears now before counsel--

10 MR. FAIRTLOUGH:

Your Honor, it's already been done.

11 MR. GOLDBERG:

Oh, it's been done. I'm sorry.

12 MR. BLASIER:

Mr. Matheson, you were asked a number of questions about an experiment that you performed last night. Do you recall that?

13 MR. MATHESON:

Yes.

14 MR. BLASIER:

Now, when you performed that experiment, did you videotape or take any photographs of what you were doing?

15 MR. MATHESON:

No, I did not. I was the only one left in the lab.

KEY QUOTE
16 MR. BLASIER:

Did you invite anybody from the Defense to observe?

17 MR. MATHESON:

No, I did not.

18 MR. BLASIER:

And a lot of the numbers that you've used for purposes of your demonstration are numbers based on your guess as to how someone else may have done withdrawals at particular times, correct?

19 MR. GOLDBERG:

Misstates the evidence.

20 THE COURT:

Sustained. Rephrase the question.

21 MR. BLASIER:

You had no personal knowledge of how a number of the withdrawals that you testified about were actually done, correct?

22 MR. MATHESON:

Personal--personal knowledge, because I was involved with at least two of them. The other ones, no.

23 MR. BLASIER:

Now, when we visited the lab in January, Mr. Taylor did his measurements with a ruler. Do you recall that?

24 MR. MATHESON:

Yes, I do.

25 MR. BLASIER:

That was after you had done your precise measurement of 2.6 milliliters, wasn't it?

26 MR. MATHESON:

It was after I did my measurement, yes.

27 MR. BLASIER:

Were you asked any questions at all by me or Mr. Goldberg about any measurement that resulted from a photograph of the ruler?

28 MR. MATHESON:

No.

29 MR. BLASIER:

When we were in the lab, were we permitted to open up the blood and take the blood out?

30 MR. MATHESON:

No, you were not.

31 MR. BLASIER:

Now, you testified previously that your records indicate that as of June 20th, according to toxicology, there is 5.5 milliliters in that tube, correct?

32 MR. MATHESON:

That--that's what was in on that form, yes.

33 MR. BLASIER:

And that's as of June 20th. At that time, there had only been one withdrawal from that blood vial that we know about, correct, from the records?

34 MR. MATHESON:

That's correct.

35 MR. BLASIER:

And assuming again hypothetically that you started with eight, Mr. Yamauchi indicated that approximately one milliliter was taken out for typing, correct?

36 MR. MATHESON:

Yes.

37 MR. BLASIER:

Incidentally, you don't need nearly one milliliter to do the kind of typing you did, do you?

38 MR. MATHESON:

The kind of typing who did?

39 MR. BLASIER:

Mr. Yamauchi did on the 14th.

40 MR. GOLDBERG:

Not relevant, beyond the scope.

41 THE COURT:

Overruled.

42 MR. MATHESON:

Well, actually, I believe the reference was that he used a milliliter for swatching, not just for his testing.

43 MR. BLASIER:

Okay. Now, for the type of swatching that he did, do you need a milliliter or do you actually use a lot less?

44 MR. GOLDBERG:

Calls for speculation.

45 MR. BLASIER:

If you know.

46 MR. MATHESON:

Well, my understanding is, you use a milliliter for those fitzco cards, the ones that we demonstrated before.

47 MR. BLASIER:

Okay. Now, would you agree that under the hypothetical, as of June 20th, there is 1.5 milliliters, Mr. Simpson's blood, that according to your records and assuming my hypothetical of starting with eight, that are not there at that point?

48 MR. GOLDBERG:

Argumentative, asked and answered.

49 THE COURT:

Overruled.

50 MR. MATHESON:

With all the assumptions in place, yes, it would be approximately 1.5.

KEY QUOTE
51 MR. BLASIER:

And as of that date, there's only been one pipetter that went into that tube according to the records, correct?

52 MR. MATHESON:

That's correct.

53 MR. BLASIER:

And did you--in the course of your experiment, did you determine how much you would have lost by putting a pipetter in one time to determine how much of that 1.5 milliliters would have been used up that way?

54 MR. MATHESON:

No, I didn't. Just the aggregate of all the ones.

55 MR. BLASIER:

Certainly it would be an extremely small amount; would you agree?

56 MR. MATHESON:

It would be small, yes.

57 MR. BLASIER:

Would you also agree that the pipetters that are used--well, let me ask you this. How much do the pipetters that you've demonstrated to us hold?

58 MR. GOLDBERG:

No foundation.

59 THE COURT:

Overruled.

60 MR. MATHESON:

Which pipetters are we talking about?

61 MR. BLASIER:

Well, do you know what kind of pipetter Mr. Yamauchi used?

62 MR. MATHESON:

For his one milliliter?

63 MR. BLASIER:

Yes.

64 MR. MATHESON:

No, I do not.

65 MR. BLASIER:

The $300 pipetter that you showed us this morning has a plastic tip on it, correct?

66 MR. MATHESON:

Yes, it does.

67 MR. BLASIER:

And do you know who manufactures that plastic tip?

68 MR. MATHESON:

No. It's called an art tip, a-r-t, but I don't know--I can't think of the manufacturer right now.

69 MR. BLASIER:

Are you aware that some plastic tips have a coating on it to prevent liquids from adhering to them?

70 MR. GOLDBERG:

Assumes facts not in evidence.

71 THE COURT:

Overruled.

72 MR. MATHESON:

I don't know if they're specifically coated with anything, no.

73 MR. BLASIER:

But are you aware that plastic tips don't have--don't--that blood or other fluids don't adhere to plastic tips as they might to glass?

74 MR. GOLDBERG:

Assumes facts not in evidence.

75 THE COURT:

Overruled. Do you know that?

76 MR. MATHESON:

I would say it depends on the plastic, it depends on the glass.

77 MR. BLASIER:

Now, the--using the $300 pipetter, how much does that plastic tip hold?

78 MR. MATHESON:

Well, the pipetter that I demonstrated here is a 1,000 microliter or one ml capacity. When you draw it up, there's a little space on top of it. So--but you don't want to--I mean, that's your maximum, is one milliliter, but it could hold a little more.

79 MR. BLASIER:

And the--the little plastic one with the bulb built into the top, how much does that hold?

80 MR. MATHESON:

I don't know.

81 MR. BLASIER:

Is that--is there a marking on there to indicate one milliliter?

82 MR. MATHESON:

I can take a look at the one we have and see if it says something on it.

83 MR. BLASIER:

Okay.

84 MR. MATHESON:

No, I don't see any markings on it at all.

85 MR. BLASIER:

Now, the dispo--the glass one that doesn't have the bulb on it, does that have any markings on it?

86 MR. MATHESON:

No.

87 MR. BLASIER:

Would you agree that a trained forensic scientist who intended to draw one milliliter out of a blood vial would know the difference between one milliliter and two and a half milliliters?

88 MR. GOLDBERG:

Calls for speculation.

89 THE COURT:

Overruled.

90 MR. MATHESON:

Yes, I would think so.

91 MR. BLASIER:

Now, you indicated that when you take the tops off of these purple top vials, a lot of times you get blood that comes out of them, correct?

92 MR. MATHESON:

Well, I think I mentioned that there's some adhering to the cap, and when you remove it, some of the times, that gets transferred onto the chem-wipe.

93 MR. BLASIER:

And are you aware of what's known as an aerosol effect?

94 MR. GOLDBERG:

Goes beyond the scope of redirect--recross.

95 THE COURT:

Overruled.

96 MR. MATHESON:

Yes, I am.

97 MR. BLASIER:

What is that?

98 MR. MATHESON:

Well, it's when you, you know, apply some force or something with the liquid, it forces it out in very small droplets.

99 MR. BLASIER:

In almost like a spray if you had a spray bottle of something?

100 MR. MATHESON:

Yeah. That's an aerosol effect too. You're taking, squirting a spray bottle and putting it into the air.

101 MR. BLASIER:

And that blood would have DNA in it, correct?

102 MR. GOLDBERG:

Beyond the scope.

103 THE COURT:

Overruled.

104 MR. MATHESON:

The blood that is aerosolized?

105 MR. BLASIER:

Yes.

106 MR. MATHESON:

Yes.

107 MR. BLASIER:

And you use the term in your redirect examination "splattering," correct? Do you remember using that term?

108 MR. MATHESON:

Blood spatter, yes.

109 MR. BLASIER:

No. I think it was splattering.

110 THE COURT:

In what context, counsel?

111 MR. BLASIER:

In terms of when you opened the tube, having blood come off of the top.

112 THE COURT:

I think he's already described that.

113 MR. BLASIER:

Okay.

114 MR. BLASIER:

Now, when we were at the lab in January, Mr. Taylor, myself and several others, we asked you specific questions about the withdrawals from this reference tube, didn't we?

115 MR. MATHESON:

I believe so, yes.

116 MR. BLASIER:

And you told us that when you did your withdrawal on the 27th, you put what you didn't use back, correct?

117 MR. GOLDBERG:

Asked and answered.

118 THE COURT:

Overruled. I assume this is foundational for something else.

119 MR. BLASIER:

Yes.

120 MR. MATHESON:

Yes, I did, but I believe I probably qualified it with, you know, to the best of my knowledge or something like that.

121 MR. BLASIER:

Do you remember doing that? Do you remember putting any qualifications on it at all?

122 MR. MATHESON:

No, but I normally do if I don't have very specific memory of something.

123 MR. BLASIER:

Was your recollection better in January than it is today as to whether you put the blood back?

124 MR. GOLDBERG:

Assumes facts not in evidence, that he had a recollection of it.

125 THE COURT:

Rephrase the question.

126 MR. BLASIER:

You wouldn't have told us that you put it back if that wasn't your recollection, would you?

127 MR. GOLDBERG:

Assumes facts not in evidence.

128 THE COURT:

It's argumentative the way it's phrased.

129 MR. BLASIER:

When you talked to us, did you tell us to the best of your knowledge what you had done with the blood that you used?

130 MR. GOLDBERG:

Asked and answered already.

131 THE COURT:

Overruled.

132 MR. MATHESON:

Yes, I did.

133 MR. BLASIER:

Now, do you recall us having a discussion about how much was used in toxicology and where that .70 figure came from?

134 MR. MATHESON:

Are we talking about in court or--

135 MR. BLASIER:

No. I'm sorry. In January.

136 MR. MATHESON:

No, I do not.

137 MR. BLASIER:

Now, the micro centrifuge tube, that's the tube that went to toxicology, correct?

138 MR. MATHESON:

I believe it's the one that was prepared by them.

139 MR. BLASIER:

And that holds a maximum of 1.5, correct?

140 MR. MATHESON:

That's correct.

141 MR. BLASIER:

And by your measurements, when it got back and got put back in the envelope, it had .8 left, didn't it?

142 MR. MATHESON:

I believe so, yes.

143 MR. BLASIER:

And that would indicate, would it not, that .7 was no longer there?

144 MR. MATHESON:

That's correct.

145 MR. BLASIER:

Do you remember a discussion at that same meeting--incidentally, Mr. Yamauchi was present as well, wasn't he?

146 MR. MATHESON:

He might have been. He was involved in a number of those.

147 MR. BLASIER:

And do you recall a discussion at that time that involved him about how much he actually withdrew on the 27th?

148 MR. GOLDBERG:

Calls for hearsay.

149 MR. BLASIER:

I'm sorry. The 25th.

150 THE COURT:

Sustained.

151 MR. BLASIER:

Do you recall during that meeting taking any issue with anything that Mr. Yamauchi said about what he had done?

152 MR. GOLDBERG:

Still calls for hearsay, not relevant.

153 THE COURT:

Overruled.

154 MR. MATHESON:

I don't have any specific recollection of that.

155 MR. BLASIER:

Now, what does the term "examiner bias" mean?

156 MR. GOLDBERG:

Not relevant.

157 THE COURT:

Overruled.

158 MR. MATHESON:

Well, my understanding of that would be is that "examiner" being the person that's doing the work, I can have a certain bias or slant or, you know, something along that line that exists within him.

159 MR. BLASIER:

Is it another way of stating that, that sometimes an examiner might come to the conclusion that he thinks he's supposed to come to, not necessarily fraudulently or--but just because you know the result and you tend to see what you think is supposed to be there? Do you understand what I just said?

160 MR. MATHESON:

Not really, no.

161 MR. BLASIER:

I don't think I did either. Doesn't that mean that your preconceived idea of what the test results should be has been shown by studies to possibly affect the result that you actually see?

162 MR. GOLDBERG:

Beyond the scope of this witness' expertise.

163 THE COURT:

Sustained the way that's phrased.

164 MR. BLASIER:

Well, tell us what you mean by the term "examiner bias."

165 MR. MATHESON:

Well, if a person has a bias, then they have a preconceived notion or a leaning towards one particular idea or something.

166 MR. BLASIER:

And one of the techniques--and I think you testified about this--in terms of how much information you know versus not having any information, is to read test results in a blind sense where you don't know anything else about the rest of the case, so you don't have any preconceived idea what the answer is supposed to be, correct?

167 MR. MATHESON:

That's correct.

168 MR. BLASIER:

Now, you remember the cranberry juice we talked about, Mr. Goldberg asked you about a little while ago?

169 MR. MATHESON:

Yes, I do.

170 MR. BLASIER:

And I represented to you when we did that little experiment that there was--it started with eight milliliters, correct?

171 MR. MATHESON:

Yes, you did.

172 MR. BLASIER:

Now, when you look at a tube--we measured that in a little graduated container, correct?

173 MR. MATHESON:

Yes.

174 MR. BLASIER:

And you recognize that as the type of container that you use if you want to measure quantities or one of the types, correct?

175 MR. MATHESON:

It's one of the types available, yes.

176 MR. BLASIER:

And when you pour something in there and you hold it up and you estimate how much is in there, you look at the liquid and you compare it to the markings on the tube, correct?

177 MR. MATHESON:

That's correct.

178 MR. BLASIER:

And when you looked at that, did you take your measurement from--well, withdraw. When liquid is in a tube like that, a relatively small tube, it tends to bow down in the middle, doesn't it?

179 MR. MATHESON:

Yes, it does.

180 MR. BLASIER:

So if you take a measurement from the bottom of the bow, it's going to be different from the top of the bow, isn't it?

181 THE COURT:

Are you talking about the meniscus?

182 MR. BLASIER:

Meniscus.

183 MR. MATHESON:

Yes, if you take it from the top. You're supposed to take it from the bottom of the meniscus.

184 MR. BLASIER:

Now, if I indicated to you hypothetically that when I measured the eight, I took it from the top, that would have been an incorrect way to measure it?

185 MR. GOLDBERG:

Well, your Honor, that's improper.

186 THE COURT:

Sustained.

187 MR. BLASIER:

You would get a difference if you measure it from the top versus the bottom?

188 MR. MATHESON:

Of the meniscus, yes.

189 MR. BLASIER:

Okay. Now, I want to ask you a couple questions about security at the lab. Now, the computer printouts that you identified and testified to on redirect only include lists of employees who may have entered those rooms by presenting their id card, correct?

190 MR. MATHESON:

That's correct.

191 MR. BLASIER:

And anybody who initially enters that unit that may have somebody else with them when they go in, that second person is not going to show up on any record anywhere, correct?

192 MR. MATHESON:

That's correct.

193 MR. BLASIER:

In fact, the times that we've been out there where you've shown us that room, our names don't appear on any computer printout as a result of going into that room, correct?

194 MR. MATHESON:

Right, because you're not issued a card.

195 MR. BLASIER:

And that particular--and--for instance, on the morning of June 14th, if Detective Lange was in that room, he doesn't show up on any printout either, does he?

196 MR. GOLDBERG:

Improper hypothetical.

197 THE COURT:

Overruled.

198 MR. MATHESON:

No, his name wouldn't show up. He doesn't have a security card for our facility.

KEY QUOTE
199 MR. BLASIER:

Incidentally, the detectives that you work with in robbery-homicide, for instance, they know where the evidence processing room is, don't they?

200 MR. MATHESON:

I don't think all of them would. Ones that have been in our facility would.

201 MR. BLASIER:

And when you dry the blood swatches, they're always dried in that cabinet up on the wall, aren't they?

202 MR. MATHESON:

That's our designated drying spot, yes.

203 MR. BLASIER:

And the records that you testified to only show when a door is opened, correct?

204 MR. MATHESON:

Actually, it only shows when somebody displays their card. It reads the card, then it unlocks it.

205 MR. BLASIER:

Now, does--is any record--is there any record in the computer when somebody who is inside the room goes out?

206 MR. MATHESON:

No, there's not.

207 MR. BLASIER:

So those records, there's no way you can tell from those records how long people who went in at a particular time stayed there?

208 MR. GOLDBERG:

This has been asked and answered.

209 THE COURT:

Overruled.

210 MR. MATHESON:

That's correct.

211 MR. BLASIER:

Now, the garage door that we've been referring to, the roll-up door, does that require any kind of card entry from the outside?

212 MR. GOLDBERG:

Assumes it can be opened from the outside.

213 THE COURT:

Overruled.

214 MR. MATHESON:

That door does not require a card to open it up, no.

215 MR. BLASIER:

So if that door were opened, there would be no record, no computer record of who might have gone in that door or who might have gone out of it?

216 MR. MATHESON:

Well, to open that door, we would have a record of who was in the evidence processing room because that's where you open it from. Once it was opened, no, then we would not have a record of it.

217 MR. BLASIER:

Well, let's assume--I'm sorry. Were you done?

218 MR. MATHESON:

Yes.

219 MR. BLASIER:

Let's assume that you have Mr. Fung come into the evidence processing room with somebody with him. Now, that entry would show up and it would show up as Mr. Fung, correct?

220 MR. MATHESON:

That's correct.

221 MR. BLASIER:

And then the door is open and Mr. Fung leaves, but the second person stays. There would be no record that the second person was in there alone, would there?

222 MR. GOLDBERG:

Improper hypothetical.

223 THE COURT:

Overruled.

224 MR. MATHESON:

That's correct.

225 MR. BLASIER:

Now, the documents that you testified to are only authorized entries into that room, correct?

226 MR. MATHESON:

Yes.

227 MR. BLASIER:

If somebody was able to get into that room who was unauthorized without triggering the computer system, there would be no record of that, correct?

228 MR. MATHESON:

Not on that printout, no.

229 MR. BLASIER:

Now, you also indicated on redirect that--you were asked some questions about evidence possibly being moved from a crime scene. Do you recall that, in terms of whether there's full documentation by taking pictures?

230 MR. MATHESON:

Oh, as to whether or not it had been moved from its original location prior to collection?

231 MR. BLASIER:

Correct.

232 MR. MATHESON:

Yes, I do.

233 MR. BLASIER:

And you recall stating that as long as you had a picture of it before it was moved and a picture of it after, then that would be sufficient documentation for you?

234 MR. GOLDBERG:

Misstates the evidence.

235 THE COURT:

Sustained.

236 MR. BLASIER:

Well, do you recall making a statement about the fact that if you had a picture of it in its original position and a picture of it later when it may have been moved, that that in your view was sufficient documentation of that item?

237 MR. MATHESON:

It's sufficient documentation of the fact that it had moved, yes.

238 MR. BLASIER:

Tells you nothing about what was done with it between the first picture and the second picture, does it?

239 MR. MATHESON:

That's correct.

240 MR. BLASIER:

Tells nothing about whether someone picked it up, took it someplace, held it and then put it back, does it?

241 MR. GOLDBERG:

Argumentative.

242 THE COURT:

Sustained.

243 MR. BLASIER:

Now, you were asked some questions on redirect about the blanket. And do you recall testifying that you wouldn't have collected that, and one of the reasons being that it appeared to have just the victim's blood on it? Remember saying that?

244 MR. GOLDBERG:

Misstates the testimony.

245 THE COURT:

Sustained. It's incomplete.

246 MR. BLASIER:

Do you recall the reasons why--tell us the reasons that you told us yesterday as to why you wouldn't have collected that blanket.

247 MR. GOLDBERG:

Still misstates the testimony.

248 THE COURT:

Overruled.

249 MR. MATHESON:

Well, I believe I said I probably wouldn't. You know, it depends. There is some variation in how we work when we're out in the field, and I think--the reasons that come to mind is that it is an item that was brought into the scene after the fact, it was not present when the crime occurred and that, you know, if you're visually looking at it and it is very heavily blood-stained, having being placed--having known to be placed over the victim, the assumption is that the majority of the blood on there is going to be from the victim and it is not--does not have a lot of evidentiary value associated with it.

250 MR. BLASIER:

Now, let's assume hypothetically that there were drops of blood on the victim's shoulder area from some source other than the victim and a blanket was put over the top of that. Could that blood transfer to the blanket?

251 MR. GOLDBERG:

Assumes facts not in evidence. Improper hypothetical.

252 THE COURT:

It's a hypothetical question. Overruled.

253 MR. MATHESON:

If that blood is damp, yes, it could transfer to the blanket.

254 MR. BLASIER:

So under that hypothetical, that blanket, if that indeed happened, could have contained the blood of someone other than the victim?

255 MR. MATHESON:

Given the hypothetical, yes.

256 MR. BLASIER:

Now, you were asked some questions on redirect about getting to the crime scene before the Coroner. Do you recall those?

257 MR. MATHESON:

I believe there was some--yes. About when the Coroner should be called and the bodies removed.

258 MR. BLASIER:

Now, you also were asked some questions about whether it's preferable to process a crime scene during daylight hours or during nighttime hours, correct?

259 MR. MATHESON:

Yes.

260 MR. BLASIER:

Do you have any information indicating that the reason the detectives did not call CID or SID for seven hours had anything to do with processing the crime scene in daylight hours versus nighttime hours?

261 MR. GOLDBERG:

Argumentative. Calls for hearsay.

262 THE COURT:

Calls for speculation.

263 MR. BLASIER:

Now, I think you indicated that at some point, detectives may decide to process a crime scene themselves?

264 MR. MATHESON:

Yes, that does occur.

265 MR. BLASIER:

Including making swatches?

266 MR. MATHESON:

Yes.

267 MR. GOLDBERG:

Misstates the testimony as to making swatches.

268 THE COURT:

Overruled.

269 MR. BLASIER:

Including logging evidence?

270 MR. MATHESON:

Yes.

271 MR. BLASIER:

Do you have any information indicating that the detectives that were at the Bundy scene between approximately 12:00 and when SID arrived later that morning processed any evidence that they recorded?

272 MR. GOLDBERG:

Misstates the testimony, your Honor.

273 THE COURT:

Overruled.

274 MR. GOLDBERG:

12:00?

275 THE COURT:

The jurors know what time--the time sequence. Any evidence of that to your knowledge?

276 MR. MATHESON:

Not that I can recall at this moment.

277 THE COURT:

All right.

278 MR. BLASIER:

Now, you were also asked on redirect examination if you had seen any evidence or indication of evidence being tampered in this case. Remember being asked that?

279 MR. MATHESON:

Yes.

280 MR. BLASIER:

Now, would you agree that by your testimony, you don't know how many swatches were collected, so you can not tell us if the number of swatches that are in the evidence now is the same number as the number of swatches collected originally?

281 MR. GOLDBERG:

Asked and answered, argumentative, beyond the scope.

282 THE COURT:

Overruled.

283 MR. MATHESON:

That's correct.

284 MR. BLASIER:

Now, you learned at some point that Andrea Mazzola's initials were not on many of the bindles that relate to the blood drops that were collected?

285 MR. GOLDBERG:

Calls for hearsay, vague as to "many," beyond the scope.

286 THE COURT:

Overruled.

287 MR. BLASIER:

You became aware of that; did you not?

288 MR. MATHESON:

I believe so, yes.

289 MR. BLASIER:

In fact, you became aware that her initials didn't appear on any of the bindles, correct?

290 MR. GOLDBERG:

Misstates the testimony.

291 THE COURT:

Overruled. Were you aware of that?

292 MR. MATHESON:

That they didn't appear on any of them?

293 THE COURT:

Yes.

294 MR. MATHESON:

Not as I'm remembering right now.

295 MR. BLASIER:

And would you agree that--well, you were also aware of Andrea Mazzola's testified--or testimony at the so-called split hearing in August I believe?

296 MR. GOLDBERG:

Not relevant.

297 THE COURT:

Sustained.

298 MR. BLASIER:

You indicated you were asked some questions about contamination and an article by Bruce Budowle of the FBI. Do you recall those questions?

299 MR. MATHESON:

Yes, I do.

300 MR. BLASIER:

And do you recall making a statement yesterday in redirect to the effect that contamination becomes a problem if it's occurring and you don't know it's happening?

301 MR. GOLDBERG:

Misstates the testimony.

302 THE COURT:

Overruled.

303 MR. MATHESON:

Yeah. In use of the word "problem," because contamination does occur, if it's going on, you don't know about it, that is a problem.

304 MR. BLASIER:

And if it's going on and you don't know about it, you have no way of knowing how it might affect test results, do you?

305 MR. MATHESON:

If I don't know about it, that's correct.

306 MR. BLASIER:

So if it--if there was evidence in your laboratory of persistent contamination that you were unaware of, would you agree that would be a serious problem?

307 MR. GOLDBERG:

Improper hypothetical, argumentative. It's also logically impossible.

308 THE COURT:

Overruled.

309 MR. BLASIER:

Would you agree that would be a serious problem?

310 MR. MATHESON:

If there was something going on that we had no idea it was going on?

311 MR. BLASIER:

Contamination.

312 MR. MATHESON:

Given that assumption, that something like that could happen, that would be a problem.

313 MR. BLASIER:

Now, you were asked some questions about the computer system and the fact that it's password protected. Do you remember that?

314 MR. MATHESON:

Yes, I do.

315 MR. BLASIER:

And a password is a secret word that you're given if you're allowed to have access to a computer so that you can actually get at the work foray, correct?

316 MR. MATHESON:

That's correct.

317 MR. BLASIER:

And what that means is, if you don't have that word, you can sit there and punch buttons all day, and you're not going to be able to get into the computer, correct?

318 MR. MATHESON:

That's correct.

319 MR. BLASIER:

Now, that particular protection that you described wasn't in effect for any of the evidence in this case until the 16th of June, correct?

320 MR. GOLDBERG:

Vague. Overbroad.

321 THE COURT:

Overruled. I think we're already established the date that these things were entered into the computer, correct?

322 MR. BLASIER:

Correct.

323 THE COURT:

All right.

324 MR. BLASIER:

Your Honor, could we take down that exhibit and--

325 MR. BLASIER:

Mr. Matheson, do you recall yesterday, you were asked about biological contamination in the context of whether having one sample contaminated with biological fluid from another sample could cause the first sample to change type? Remember that?

326 MR. MATHESON:

Yes. I think we've talked about it a couple times.

327 MR. BLASIER:

And you said that that can't happen?

328 MR. MATHESON:

In actually changing the type?

329 MR. BLASIER:

Yes.

330 MR. MATHESON:

That's my understanding, yes.

331 MR. BLASIER:

Now, when you're talking about actually changing the type, let me shift that just a little bit and ask you the same question about being able to detect--well, let me rephrase that. The only way we have of knowing what a type is is by the test, correct?

332 MR. MATHESON:

That's correct.

333 MR. BLASIER:

Now, is it your testimony that if you have a biological sample from one person and another biological sample is added to that from a second person, that the results of the test would never change?

334 MR. MATHESON:

No, I did not say that.

335 MR. BLASIER:

Now, could we have slide--can we have--I need a number for the slide presentation.

336 THE COURT:

Defense next in order?

337 THE CLERK:

1143.

338 MR. BLASIER:

1143?

339 THE COURT:

1143-A.

340 (Deft's 1143 for id = slide)
341 MR. BLASIER:

Now, Mr. Matheson, remember yesterday we were talking about that you get--genetic markers come from our parents, don't they?

342 MR. MATHESON:

Yes.

343 MR. BLASIER:

And we talked in the context of the EAP system, of there being A's, B's and C's and you get one of those from each parent, correct?

344 MR. MATHESON:

That's correct.

345 MR. BLASIER:

Same thing is true with other genetic markers that are looked at in DNA testing and other conventional serology testing, correct?

346 MR. MATHESON:

Yes. The concept's the same.

347 MR. BLASIER:

Each marker system has its own universe if you will of possible alleles they're called within that marker, correct?

348 MR. GOLDBERG:

Beyond the scope, your Honor.

349 THE COURT:

Overruled.

350 MR. BLASIER:

Correct?

351 MR. MATHESON:

That's correct.

352 MR. BLASIER:

And one of the marker systems that you--in fact you look at in your lab is called the DQ-alpha marker which is--that just identifies a particular part of the DNA that's looked at, correct?

353 MR. MATHESON:

Yes, that's true.

354 MR. BLASIER:

And that's a primary test that your lab performs, isn't it?

355 MR. MATHESON:

That's one of a couple tests, yes.

356 MR. BLASIER:

And two of the alleles that happen to be in that system are called 1.1 and 1.2, aren't they?

357 MR. MATHESON:

Yes.

358 MR. BLASIER:

It's kind of the equivalent of the A's and B's and C's, correct?

359 MR. GOLDBERG:

This is beyond the scope, your Honor.

360 THE COURT:

Overruled. But move it along, Mr. Blasier. This is just to make a point.

361 MR. BLASIER:

Yes. Correct.

362 THE COURT:

All right. Let's get there.

363 MR. MATHESON:

That's a designation, yes.

364 MR. BLASIER:

Now, if you inherit that 1.1 from your mother and 1.1 from your father, then you're going to be a 1.1, correct?

365 MR. GOLDBERG:

Beyond the scope.

366 THE COURT:

Overruled.

367 MR. MATHESON:

Yes.

368 MR. BLASIER:

And correspondingly, if person B up there inherits a 1.2 from mom, a 1.2 from dad, that person is going to be a 1.2, correct?

369 MR. MATHESON:

Yes.

370 MR. BLASIER:

Now, if you take a little bit of blood from a and a little bit of blood from B and mix it together and run a test on it, you're going to get a type 1.1, 1.2, correct?

371 MR. GOLDBERG:

Vague as to "little bit."

372 THE COURT:

Overruled.

373 MR. MATHESON:

Depending on the concentrations of each, yes, you're going to see those two.

374 MR. BLASIER:

So assume they're approximately the same.

375 MR. MATHESON:

That's what the test would read then, yes.

376 MR. BLASIER:

And the 1.1, 1.2 type is different from either of the two types that went into it, correct?

377 MR. MATHESON:

When taken together, that's correct.

378 MR. BLASIER:

Now, would you agree that that is an example of where you could have a mixture of blood from two people that would type differently from either one that's in it?

379 MR. MATHESON:

It would change the result you see, yes. Not the type of either one of them.

380 MR. BLASIER:

But all we have is the results, correct?

381 MR. MATHESON:

That's correct.

382 MR. GOLDBERG:

Argumentative.

383 THE COURT:

Overruled.

384 MR. BLASIER:

Now, you also indicated yesterday that the nature of the genetic markers that you deal with, one marker might--I think the term you used was--overpower or one might degrade, correct?

385 MR. GOLDBERG:

Beyond the scope. That wasn't on redirect.

386 MR. BLASIER:

Yes, it was.

387 THE COURT:

Overruled.

388 MR. MATHESON:

I'm sorry. Could you repeat that?

389 MR. BLASIER:

Yeah. Let me--let me read your question and answer from yesterday and see if this refreshes your memory or let me show it to you.

390 MR. GOLDBERG:

It's irrelevant whether he can remember his testimony from yesterday.

391 THE COURT:

Overruled.

392 (Brief pause.)
393 MR. MATHESON:

Yes.

394 MR. BLASIER:

Do you recall that yesterday?

395 MR. MATHESON:

Yes.

396 MR. BLASIER:

And the concept you were talking about there was, if you have this mixture that we've been talking about, if you've got part of the mixture as either degraded or that you only got a little bit, it may be overpowered by the other component, correct?

397 MR. GOLDBERG:

Asked and answered, beyond the scope.

398 THE COURT:

Overruled.

399 MR. MATHESON:

Yes.

400 MR. BLASIER:

Now, in my example, my hypothetical up there, would you agree that if person number a had been--that sample had been degraded or it was only a small sample and person number B had a lot there and you mix them together and did a test, person number B might overwhelm person number a, correct?

401 MR. GOLDBERG:

Asked and answered.

402 THE COURT:

Overruled.

403 MR. MATHESON:

Yes, that's possible.

404 MR. BLASIER:

And--

405 MR. BLASIER:

Have that slide, please, slide b.

406 MR. BLASIER:

Would you agree that that--in my hypothetical, that would result in your final test of this mixture showing person b, but not person a?

407 MR. MATHESON:

Assuming that the quantity of B was sufficiently high, yes, that could occur.

408 MR. BLASIER:

Now, let's assume hypothetically that the blood from person a is put on a swatch and is put in a--while still damp in a plastic bag, is put in a truck in the middle of June for a period of time. Would you agree that that could cause that to start degrading?

409 MR. MATHESON:

Well, I think, like I mentioned before, as soon as blood leaves the body, degradation begins.

410 MR. BLASIER:

Okay. And the degradation simply means the little pieces of DNA are kind of breaking up and you lose the ability to detect them, correct?

411 MR. GOLDBERG:

Beyond the scope, your Honor.

412 THE COURT:

Sustained.

413 MR. BLASIER:

And if hypothetically, blood from person B gets put on that swatch later on after a has started to break down, then you might get the hypothetical that's up on the projector?

414 MR. GOLDBERG:

Beyond the scope.

415 THE COURT:

It's an improper hypothetical. Sustained.

416 MR. BLASIER:

Now, Mr. Matheson, I want to ask you a couple questions about the EAP testimony that you gave on redirect. Do you recall Mr. Goldberg asked you specific questions about the articles that I had referred you to? Do you remember that?

417 MR. MATHESON:

Yes, I do.

418 MR. BLASIER:

Now, let me ask you first of all, the only article that you referred to on direct was the Zajac, Grunbaum and Crim article, correct?

419 MR. GOLDBERG:

That's irrelevant, your Honor.

420 THE COURT:

Overruled.

421 MR. MATHESON:

That was the only one presented to me, yes.

422 MR. BLASIER:

Now, let me show you that article. When's the last--have you read that recently?

423 MR. MATHESON:

I've read this and--yes. It's been within the last several days.

424 MR. BLASIER:

And you've given testimony on redirect about the manner of degradation of an EAP; have you not?

425 MR. MATHESON:

Yes, I have.

426 MR. BLASIER:

I'm sorry. Of a BA.

427 MR. MATHESON:

That's correct.

428 MR. BLASIER:

Would you agree that that particular article that you referred to, nowhere in it talks about how a BA degrades in terms of what happens to the bands, does it?

429 MR. MATHESON:

Did you ask whether or not it makes any reference to any form of specific type of degradation?

430 MR. BLASIER:

No. My question is, it doesn't tell you which bands you lose in what order when you degrade a BA, does it?

431 MR. MATHESON:

No, it does not.

432 MR. BLASIER:

Can we have slide c.

433 THE COURT:

C.

434 MR. BLASIER:

Now, you recall yesterday we had a slide similar to this to illustrate the path of degradation of a BA down to a b, correct?

435 MR. MATHESON:

It had similarities to this, yes.

436 MR. BLASIER:

Now, one article that you were shown by or asked about by Mr. Goldberg on redirect was the Yeshion article. Remember that?

437 MR. MATHESON:

Yes.

438 MR. BLASIER:

And you testified that article said nothing about the manner in which a BA degrades in terms of which bands disappear first. Remember that?

439 MR. GOLDBERG:

That misstates the testimony.

440 THE COURT:

Rephrase the question.

441 MR. BLASIER:

Do you recall testifying that that article did not describe the path of degradation of a BA?

442 MR. GOLDBERG:

No. Misstates the testimony.

443 THE COURT:

Overruled.

444 MR. MATHESON:

My understanding of the article is that I believe it describes a different--the focus of the article is a different degradation, the B to a CB or something like that.

445 MR. BLASIER:

Okay. Let me show you that article and ask you to read the first paragraph under "discussion."

446 MR. MATHESON:

Okay. Under discussion, it says, "several studies--"

447 THE COURT:

Just read it to yourself.

448 MR. MATHESON:

Oh, I'm sorry.

449 (The witness complies.)
450 MR. MATHESON:

Okay.

451 MR. BLASIER:

Now, that article does describe the path of degradation in terms of which bands disappear first, doesn't it?

452 MR. MATHESON:

It does have a two-line reference to it, yes.

453 MR. BLASIER:

And it--and it--it refers to that as being an analysis of other literature on the topic, correct?

454 MR. MATHESON:

It references several studies, yes.

455 MR. BLASIER:

And it says that all of those studies describe the path of degradation the way I did on my cross-examination with you, correct?

456 MR. MATHESON:

Yes, it does.

457 MR. BLASIER:

Not the way you described it, correct?

458 MR. GOLDBERG:

Well, Mr. Matheson did describe it in one way.

459 THE COURT:

Sustained.

460 MR. BLASIER:

Not the way you described it as a result--as leading to two B bands, correct?

461 MR. MATHESON:

That's correct.

462 MR. BLASIER:

Now, you were asked a question about the book that you had referred to, the Saferstein book. Do you recall that?

463 MR. MATHESON:

Yes, I do.

464 MR. BLASIER:

And the chapter of that book that you were referring to is actually written by Dr. Sensabaugh, correct?

465 MR. MATHESON:

Yes, I believe we mentioned that.

466 MR. BLASIER:

And he--I'm sorry. And he's the same author that--of the article that I provided to you during cross-examination, correct?

467 MR. MATHESON:

That's correct.

468 MR. BLASIER:

And that article, the portion that you read from that article describes one other possible path of degradation for a BA, correct?

469 MR. MATHESON:

I think gave indication of that, yes.

470 MR. BLASIER:

And could you read again the--starting at the "thus" which you started--which you read yesterday and read down to where it says "two."

471 MR. MATHESON:

Where it says what?

472 MR. BLASIER:

Where--the next sentence where it starts with "two."

473 MR. MATHESON:

Oh, okay. Am I reading this one out loud?

474 MR. BLASIER:

Sure.

475 MR. MATHESON:

"Thus one might expect the a bands in BA and CA types to be lost before the B or C bands are lost. And this in fact has been observed." that's the end of the sentence.

476 MR. BLASIER:

Read the next sentence.

477 MR. MATHESON:

"In typing aged type BA bloodstains, for example, only the major B band," and then in parenthesis, "The anodal B band may be apparent and the temptation would be to type the sample as a B type."

478 MR. BLASIER:

And would you agree that what that says is that you might also get a path of degradation that leads you to just seeing the b-2 band and nothing else?

479 MR. MATHESON:

Yes.

480 MR. BLASIER:

And then the next part of that says what?

481 MR. MATHESON:

"Since it has been observed that in aged BA bloodstains, the slow B band is generally lost before the fast a band, the controlling rule is to withhold judgment on a punitive B type until both B bands are apparent. If the sample is in fact a BA type, the major a band should be apparent by that time."

482 MR. BLASIER:

Would you agree that what that says is that if you have both B bands, b-2 and b-2, that that cannot be a degraded BA?

483 MR. MATHESON:

No. I believe it says things like "generally" and "should." it's not an absolute.

484 MR. BLASIER:

Can you cite me to a single scientific reference that says that a BA can degrade to the point where you have two B bands and nothing else?

KEY QUOTE
485 MR. MATHESON:

No, I can not.

486 MR. BLASIER:

Could we go to slide d, please?

487 MR. BLASIER:

Now, the EAP test measures an enzyme in the blood, correct?

488 MR. MATHESON:

Yes, it does.

489 MR. BLASIER:

And it's an enzyme that's found in red blood cells, correct?

490 MR. MATHESON:

That's correct.

491 MR. BLASIER:

And our blood is made up of red blood cells and other types of cells, correct?

492 MR. GOLDBERG:

Beyond the scope.

493 THE COURT:

Overruled.

494 MR. MATHESON:

Yes.

495 MR. BLASIER:

And there is no DNA in a red blood cell, correct?

496 MR. MATHESON:

That's correct.

497 MR. BLASIER:

The DNA or DNA is found in cells other than red blood cells, correct?

498 MR. MATHESON:

Yes.

499 MR. BLASIER:

So if you're doing a DNA test on a biological fluid that contains a lot of cells, you're only looking at what's in cells other than red blood cells, correct?

500 MR. MATHESON:

For the DNA, yes.

501 MR. BLASIER:

Can we go to slide e?

502 MR. BLASIER:

Now, Mr. Matheson, you--would you agree that our hands and fingernails are made up of cells?

503 MR. MATHESON:

Yes, they are.

504 MR. BLASIER:

And would you agree that if you took scrapings from under a person's fingernails, you would expect their DNA to be in it, wouldn't you?

505 MR. MATHESON:

Their own DNA?

506 MR. BLASIER:

Yes.

507 MR. MATHESON:

If you scraped and picked up some of their skin or blood or whatever happened to be under there.

508 MR. BLASIER:

And if you did that kind of a scraping where you got cellular material from under the fingernails, if you didn't find the person's DNA, that would be unusual, wouldn't it?

509 MR. GOLDBERG:

Beyond the scope.

510 THE COURT:

Overruled.

511 MR. MATHESON:

Well, I haven't done DNA typing under fingernails. So I don't know if it would be unusual or not.

512 MR. BLASIER:

Now, you could also, could you not--let's assume hypothetically that you have a person with fingernails that scratches somebody else who has an EAP type B. Have that hypothetical in mind?

513 MR. MATHESON:

Yes.

514 MR. BLASIER:

And a small amount of that--a person's B who has an EAP type B gets under the fingernails of person A. You with me so far?

515 MR. MATHESON:

Think so.

516 MR. BLASIER:

And you took scrapings from under the fingernails and did a series of tests on them, would you agree that when you do the EAP test, you're going to detect the EAP type B from the person who was scratched, correct?

517 MR. MATHESON:

If there's sufficient blood present. It--excuse me. The detectability limit of the test.

518 MR. BLASIER:

Now, would you also agree that if you had a greater amount of material, cellular material from person a and you did a DNA test, that you would detect the DNA of person a in that mixture, wouldn't you?

519 MR. MATHESON:

If there's sufficient amount, yes.

520 MR. BLASIER:

And if the amount of DNA from person a overwhelmed the amount of DNA that might have come from the small amount of blood from person b, you'd never see person b, would you?

521 MR. GOLDBERG:

Beyond the scope. It's getting into DNA.

522 THE COURT:

Overruled. Do you understand the question?

523 MR. MATHESON:

Yes. If the quantity of DNA provided by the tissue that was scraped was significantly higher than the or sufficiently higher than the blood providing the EAP, then yes.

524 MR. BLASIER:

And would you agree that you can do as many DNA tests as you want on that mixture and you're never going to be able to prove that person B isn't there?

KEY QUOTE
525 THE COURT:

Sustained. Sustained.

526 MR. GOLDBERG:

I would ask that the jury be admonished to disregard the import of that question.

527 THE COURT:

They know that when I sustain an objection, that's the rule.

528 MR. BLASIER:

Now, Mr. Matheson, you talked about your control study that you used item 42 for, correct? Remember that?

529 MR. MATHESON:

Well, I'm saying we did type item no. 42, yes.

530 MR. BLASIER:

And I think you indicated that according to the article by Dr. Budowle, that for that kind of control study to have any value at all, the sample that you're comparing it to has to have been subjected to the same myriad of environmental insults I think is the way you described it, correct?

531 MR. GOLDBERG:

Misstates the testimony.

532 THE COURT:

Overruled.

533 MR. MATHESON:

I believe on reading that, it made reference to the fact that a blood sample collected from an area where the victim is that's known to be the victim's blood would tend to be involved in the same environmental conditions.

534 MR. BLASIER:

But if your control sample, in this case, 42 that you testified to about was subjected to different environmental conditions, then the fingernail samples--your control makes no sense. It doesn't work that way, does it?

535 MR. GOLDBERG:

It's argumentative. It states facts not in evidence.

536 THE COURT:

Sustained. Rephrase the question.

537 MR. BLASIER:

In my example, the control is not a proper control, is it, if it's not--if that sample is subjected to different conditions than the one you're comparing it to?

538 MR. GOLDBERG:

Vague as to "proper control."

539 THE COURT:

Overruled.

540 MR. MATHESON:

Well, it still is going to provide information. It is blood that you know to come from a particular person. If the environmental conditions are not exactly the same, then that is something that might be considered.

541 MR. BLASIER:

Now, you were asked some questions on redirect about wet stains versus dry stains. Remember that?

542 MR. MATHESON:

I think there was some mention of it regarding the studies, yes.

543 MR. BLASIER:

Incidentally, is there a single reference in the literature or a single study that you can point to that says that the degradation pattern of a wet stain is going to be different than a dry stain?

544 MR. MATHESON:

Not that I can recall at the moment.

545 MR. BLASIER:

Now, would you also agree that 84, the fingernails in this case, there were two samples, one from one hand, one from the other, correct?

546 MR. MATHESON:

That's correct.

547 MR. BLASIER:

And one of those samples appear to be damp because you can see the transfer of material onto the container it was put in, correct?

548 MR. MATHESON:

Yes.

549 MR. BLASIER:

The other one was dry, wasn't it?

550 MR. MATHESON:

Well, the other one appeared to be drier. It had chunks of blood down the bottom, but the tip of the stick was a little damp. So--or a little red, which may indicate that it had a little bit of dampness in it. But there was a difference.

551 MR. BLASIER:

There was a difference in the condition of those two samples, wasn't there?

552 MR. GOLDBERG:

Well, vague and overbroad as to the conditions. Calls for speculation.

553 THE COURT:

Sustained. Sustained.

554 MR. BLASIER:

Would you agree that if your theory--if your testimony about a control study is accurate, it would only apply to samples that had the same condition, similar condition?

555 MR. GOLDBERG:

Vague as to similar.

556 THE COURT:

Overruled.

557 MR. MATHESON:

I think that has to be taken into consideration, but there's still information that can be obtained.

558 MR. BLASIER:

Uh-huh. Now, I would like to show on the elmo the--I'm not sure what exhibit this is. This is the one that the Prosecution did where they printed out with the arrows on it. Do you remember yesterday you were asked to identify the--I think you described them as band-like appearances?

559 MR. MATHESON:

Yes.

560 MR. BLASIER:

From 42? Let me show you this.

561 THE COURT:

Well, let's find out what exhibit it is first.

562 MR. GOLDBERG:

I may have written the number on the back. I sometimes do. That may be 224-C.

563 MR. BLASIER:

224-C.

564 THE COURT:

All right.

565 MR. BLASIER:

Let me show you 224-C on the elmo.

566 THE COURT:

Why don't we give Mr. Matheson the other copy of that.

567 MR. BLASIER:

Sure.

568 THE COURT:

And keeping in mind the time limitations.

569 MR. BLASIER:

Yes. We're almost done.

570 THE COURT:

Mr. Blasier.

571 MR. BLASIER:

Now, Mr. Matheson, you recall that you had two arrows put where you--where you saw what you described as something kind of like a band. Remember that?

572 MR. MATHESON:

Yes.

573 MR. BLASIER:

Now, you also testified during cross that there is something kind of like a band or something that you can see between those two arrows, correct?

574 MR. GOLDBERG:

That misstates the testimony. It's also inconjunctive.

575 THE COURT:

Overruled.

576 MR. MATHESON:

There is kind of a haze in that area that's brighter than the background, yes.

577 MR. BLASIER:

And could you direct the--get an arrow put on that where you see that?

578 MR. MATHESON:

You need to go to the left, left.

579 MR. BLASIER:

Could we have the arrow on the same side, please?

580 THE COURT:

How about if we have it on opposite sides of the same lane so that we can determine who put what where?

581 MR. BLASIER:

Okay.

582 MR. MATHESON:

I guess you need to go down a little bit, down. Right kind of in that area off to the left there, there's kind of a hazy cloud of something (Indicating).

583 MR. BLASIER:

Okay. Why don't you clip that.

584 MR. BLASIER:

Now, that is in an area that would correspond to an a band, correct?

585 MR. MATHESON:

General area, yes.

586 MR. BLASIER:

Now, I want to cover up everything except that lane.

587 MR. BLASIER:

Can we print this up first?

588 (Discussion held off the record between Defense counsel.)
589 MR. BLASIER:

Mr. Matheson, I'm going to cover up everything except that lane. See that?

590 MR. MATHESON:

Yes, I do.

591 MR. BLASIER:

And the technique I'm using is what you described earlier as reading it blind, correct?

592 MR. MATHESON:

No. Actually reading blind that I mentioned before is not having any information about the case. It's very difficult and really fairly inappropriate to read a plate without the controls and things present.

593 MR. BLASIER:

There's nothing on there that you as a forensic scientist will call a band, is there?

594 MR. GOLDBERG:

This is improper, your Honor. This is not a scientifically correct way of doing it, and also the resolution is not good enough.

595 THE COURT:

Sustained. Foundation.

596 MR. BLASIER:

Is there anything in that lane that appears that you would call--as a forensic scientist under your training that you would call a band?

597 MR. GOLDBERG:

Same foundational problems.

598 THE COURT:

Overruled.

599 MR. GOLDBERG:

And the resolution is not good enough.

600 THE COURT:

Overruled.

601 MR. MATHESON:

I don't believe I've ever testified that I identified bands in that lane, but that there were things or band-like visible areas that were showing up.

602 MR. BLASIER:

Including in the area of an a band, correct?

603 MR. MATHESON:

In addition to other areas of that lane, yes.

604 MR. BLASIER:

And would you agree that your bank-like appearances are three areas of some sort of a cloudy thing that you've described, correct?

605 MR. GOLDBERG:

There's no foundation for this, your Honor. It's also vague as to "cloudy thing." it's been asked and answered.

606 THE COURT:

Overruled.

607 MR. MATHESON:

I'm sorry. Can you repeat the question?

608 MR. BLASIER:

Yes. You testified now that you see three band-like things--

609 MR. GOLDBERG:

That misstates the evidence.

610 THE COURT:

Sustained. That does.

611 MR. BLASIER:

That you see three areas on there that have a cloudy-like substance, correct?

612 MR. GOLDBERG:

That misstates the evidence.

613 THE COURT:

Sustained.

614 MR. BLASIER:

What do you see, Mr. Matheson?

615 MR. MATHESON:

I see areas on there of different intensities of a cloud-like type of appearance.

616 MR. BLASIER:

And that doesn't look anything at all like what you found under the fingernails, does it?

617 MR. GOLDBERG:

Well, that's an improper hypothetical.

618 THE COURT:

No. That's argumentative the way it's phrased.

619 MR. GOLDBERG:

That's also a picture of a picture.

620 THE COURT:

Sustained.

621 MR. BLASIER:

That doesn't look like what you found under the fingernails, does it?

622 MR. GOLDBERG:

Argumentative, your Honor.

623 THE COURT:

Sustained.

624 MR. BLASIER:

Does that look like the bands--does that have the similar appearance to the bands that you found under the fingernails?

625 MR. GOLDBERG:

Argumentative, your Honor, improper hypothetical.

626 THE COURT:

Overruled.

627 MR. MATHESON:

No, it doesn't. If it looked the same, I would have called this with the same result, and I didn't.

628 THE COURT:

All right. Let's move on.

629 MR. BLASIER:

Could we have slide--let me--

630 MR. BLASIER:

Mr. Matheson, California Association of Criminalists has a Code of Ethics; do they not?

631 MR. MATHESON:

Yes, we do.

632 MR. BLASIER:

I ask you to look at that and read the highlighted paragraph to yourself.

633 MR. GOLDBERG:

Your Honor, this is irrelevant, calls for hearsay.

634 THE COURT:

Overruled.

635 MR. MATHESON:

Okay.

636 MR. BLASIER:

And do you agree that those highlighted paragraphs are two paragraphs from the code of ethics from the California association of criminalists?

637 MR. MATHESON:

Yes, I do.

638 MR. BLASIER:

And you are a member of that organization?

639 MR. MATHESON:

Yes, I am.

640 MR. BLASIER:

And you consider yourself to be bound by those ethics?

641 MR. MATHESON:

Yes.

642 MR. BLASIER:

Your Honor, I'm wondering if we should print out a copy of that last demo I did.

643 MR. GOLDBERG:

Your Honor, I object to that because there was no foundation for a scientist looking at something that's covered up like that.

644 THE COURT:

Overruled.

645 MR. BLASIER:

Could we have slide f, please?

646 THE COURT:

Let's proceed with a little alacrity.

647 MR. BLASIER:

Mr. Matheson, would you agree that the code of ethics of your organization that you are a member of provide that: "The criminalist will be alert to recognize the significance of a test result as it may relate to the investigative aspects of a case. In this--" I'm sorry. I got it backwards. Let me read the other one. Would you agree that one of those provisions provides that: "Where test results are capable of being interpreted to the advantage of either side of a case, the criminalist will not choose that interpretation favoring the side which he is employed merely as a means of justifying his employment"? Do you agree that that's one of the provisions of your code of ethics?

648 MR. MATHESON:

Yes, I do.

649 MR. BLASIER:

Could we see the next slide, please?

650 MR. BLASIER:

Do you also agree that one of the provisions of your code of ethics is that: "The criminalist will be alert to recognize the significance of a test result as it may relate to the investigative aspects of a case. In this respect, however--in this respect, he will, however, scrupulously avoid confusing scientific fact with investigative theory in his interpretations"? Do you agree that that's one of the provisions of your code of ethics?

651 MR. MATHESON:

Yes, I do.

652 MR. BLASIER:

And do you agree that there is no scientific support for your testimony that a BA can degrade to the point where you have two B bands remaining?

653 MR. MATHESON:

No, I do not.

654 MR. BLASIER:

Isn't that what you're doing in this case, Mr. Matheson, is violating this code of ethics?

655 MR. GOLDBERG:

Your Honor, this is totally argumentative.

656 THE COURT:

Sustained. Sustained.

657 MR. BLASIER:

I have no further questions.

658 THE COURT:

Mr. Goldberg.

Temperature

tense

Key Quotes (5)

Robert Blasier
Can you cite me to a single scientific reference that says that a BA can degrade to the point where you have two B bands and nothing else?
Matheson answered 'No, I can not' — directly undermining the prosecution's redirect testimony about EAP degradation patterns and the typing results from blood evidence.
Gregory Matheson
With all the assumptions in place, yes, it would be approximately 1.5.
Matheson concedes 1.5 mL of Simpson's reference blood is unaccounted for as of June 20th, with only one documented withdrawal — central to the defense's blood-planting theory.
Gregory Matheson
No, his name wouldn't show up. He doesn't have a security card for our facility.
Establishes that Detective Lange — or any detective — could be in the evidence processing room with no computer record of their presence.
Gregory Matheson
No, I did not. I was the only one left in the lab.
Matheson admits his overnight blood-volume experiment was unwitnessed, unrecorded, and defense was not invited to observe — undercutting its credibility.
Robert Blasier
And would you agree that you can do as many DNA tests as you want on that mixture and you're never going to be able to prove that person B isn't there?
Though sustained by Ito (with Goldberg asking for jury admonishment), the question planted the idea that DNA testing cannot rule out contamination from a secondary source.

Evidence (10)

Informal
OJ Simpson reference blood vial — purple-top tube from which 1.5 mL is unaccounted as of June 20th
discussed, volume calculations challenged
Defense 1143-A
Slide illustrating EAP genetic marker inheritance and blood mixture typing
introduced, used to demonstrate how mixed blood samples can type differently from either source
People's 224-C
Printed EAP gel photograph with arrows marking band-like appearances in item 42
discussed, Matheson directed placement of additional arrow on a 'hazy cloud' region between existing arrows
Informal
Item 42 — blood stain used by prosecution as control sample for fingernail comparison
discussed, defense challenged its validity as control due to different environmental conditions
Informal
Item 84 — fingernail scrapings from Nicole Brown Simpson, two samples (one damp, one dry)
discussed, condition differences between samples highlighted
Informal
Zajac, Grunbaum and Crim article on EAP degradation
discussed, Matheson concedes it does not describe which bands disappear first in BA degradation
+ 4 more

Notable Exchanges (5)

Robert BlasierGregory Matheson
Blasier walks Matheson through the Yeshion article Goldberg had cited on redirect, getting Matheson to read and then admit the article's discussion section actually describes the BA degradation path consistent with the defense's theory — not two B bands as Matheson had testified.
revealing
Robert BlasierGregory Matheson
Blasier establishes that the lab security system has multiple blind spots: it logs card entries but not exits, records nothing about guests accompanying card-holders, and the roll-up garage door is not card-protected at all — allowing a hypothetical where a detective enters with Fung, opens the garage, and Fung leaves while the detective remains with no record.
strategic
Robert BlasierGregory Matheson
Blasier methodically accounts for the Simpson reference blood: starting at 8 mL, minus ~1 mL for Yamauchi's typing, equals ~7 mL, but toxicology records show only 5.5 mL on June 20th with one documented withdrawal — leaving ~1.5 mL unaccounted. Matheson concedes the math.
strategic
Robert BlasierGregory Matheson
Using a slide showing DNA marker alleles, Blasier demonstrates how mixing blood from two people can produce a combined type different from either source, and how degradation of one sample could cause the other to 'overwhelm' it in testing — framing a mechanism for planted blood producing different DNA results.
strategic
Robert BlasierGregory Matheson
Matheson admits his overnight blood-volume experiment was performed alone, without photographs, without videotape, and without defense notification or observation.
revealing

Light Moments (2)

Robert Blasier
Blasier attempts to ask about 'examiner bias' and ends up confusing himself mid-question: 'I don't think I did either' — openly admitting his own question made no sense before rephrasing it.
Lance A. Ito
Judge Ito interjects to supply the correct scientific term 'meniscus' when Blasier was dancing around describing the curved surface of liquid in a graduated cylinder.

Credibility Attacks (3)

⚔ Gregory Matheson
Challenging scientific methodology and prior inconsistent testimony
Blasier forced Matheson to concede his overnight blood-volume experiment was unwitnessed and undocumented, and that his redirect testimony about EAP BA degradation leading to two B bands is contradicted by the very articles Goldberg cited, including Matheson's admission he cannot cite a single study supporting two-B-band degradation.
⚔ Gregory Matheson
Prior inconsistent statement (January lab meeting)
Blasier pressed Matheson on statements made during the January defense lab visit — that he put unused blood back in the vial — suggesting his recollection was clearer then and that the qualification ('to the best of my knowledge') was added after the fact.
⚔ LAPD Crime Lab (institutional)
Demonstrating systemic security gaps
Through Matheson's admissions, Blasier established that the lab's card-access system has no exit logging, no visitor tracking, and no protection on the roll-up garage door — meaning unauthorized access would leave no computer record.

Witness Demeanor

(The witness complies.) — reading Yeshion article passage to himself
(Brief pause.) — before confirming recollection of prior testimony

Objections

65 objections (12 sustained, 50 overruled)
Proceeding 5936 • 658 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 5, 1995 📄 Recross-examination of Gregory
MAY 5, 1995 KRT DvH TD